Anaplastic thyroid carcinoma

Known as: thyroid cancer, undifferentiated carcinoma, Dedifferentiated Thyroid Gland Carcinoma, Carcinomas, Anaplastic Thyroid 
An aggressive THYROID GLAND malignancy which generally occurs in IODINE-deficient areas in people with previous thyroid pathology such as GOITER. It… (More)
National Institutes of Health

Related topics

Related topics

24 relations
Anaplastic Carcinoma CellBlood supply aspectsCoagulative necrosisDeglutition Disorders
(More)

Narrower (1)

Anaplastic Giant Cell Thyroid Carcinoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Hepatocellular carcinoma.
Copyright © 2011 Massachusetts Medical Society. Each year, hepatocellular carcinoma is diagnosed in more than half a million… (More)
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
Review
2010
Review
2010
Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.
Anaplastic thyroid carcinoma ranges from 1.3 to 9.8% of all thyroid cancers globally. Mutations, amplifications, activation of… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
MicroRNA expression profiles in serous ovarian carcinoma.
PURPOSE Although microRNAs have recently been recognized as riboregulators of gene expression, little is known about microRNA… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
BACKGROUND Anaplastic thyroid carcinoma (ATC) is rare but is one of the most aggressive human malignancies. Several prognostic… (More)
Is this relevant?
Review
2005
Review
2005
BRAF mutation in thyroid cancer.
Genetic alteration is the driving force for thyroid tumorigenesis and progression, based upon which novel approaches to the… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.
Thyroid papillary cancers (PTCs) are associated with activating mutations of genes coding for RET or TRK tyrosine kinase… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.
Beta-catenin is an ubiquitously expressed cytoplasmic protein that has a crucial role in both E-cadherin-mediated cell-cell… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].
BACKGROUND The National Cancer Data Base (NCDB) represents a national electronic registry system now capturing nearly 60% of… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy.
Ninety-one patients with histologically proven anaplastic carcinoma of the thyroid were referred to the Beatson Oncology Centre… (More)
Is this relevant?
Highly Cited
1985
Highly Cited
1985
Anaplastic thyroid carcinoma. A study of 70 cases.
Seventy cases of anaplastic thyroid carcinomas studied at the Universities of Florence (Italy) and Minnesota are presented. Three… (More)
Is this relevant?